World IBD Day 2026: 'IBD Has No Borders' and Access to Care

Every year on May 19, the global IBD community comes together for World IBD Day - the one day when our often-invisible illness is made visible across more than 50 countries. The 2026 theme, set by the International Federation of Crohn's & Ulcerative Colitis Associations, is "IBD Has No Borders: Access to IBD Care" (2). It is a deceptively simple line that names something most of us know in our bones: where you live, what insurance you have, and which specialist you can reach often shape your IBD journey as much as your biology does.

This guide walks through what the 2026 theme means, the global picture of access today, the parallel "More Than the Gut" campaign in the US, what is happening on May 19 itself, and five concrete ways to take part - even on a hard day.

Key Takeaways

• The 2026 World IBD Day theme is "IBD Has No Borders: Access to IBD Care", coordinated by IFCCA, which represents more than 50 countries (1, 2).
• Approximately 10 million people live with IBD worldwide (1).
• A 2025 systematic review and meta-analysis of 215 population-based studies estimated global IBD prevalence at 229.7 per 100,000 (3).
• The 2017 Global Burden of Disease study reported the highest age-standardised IBD prevalence in high-income North America (422.0 per 100,000) and the lowest in the Caribbean (6.7 per 100,000), reflecting both biology and diagnosis access (4).
• The Crohn's & Colitis Foundation (US) is running a parallel 2026 campaign called "IBD Is More Than the Gut", focused on mental health, pain, fatigue, and relationships during Mental Health Awareness Month (6).

The 2026 Theme: "IBD Has No Borders: Access to IBD Care"

World IBD Day is coordinated globally by IFCCA, the International Federation of Crohn's & Ulcerative Colitis Associations, which brings together patient organisations from more than 50 countries on five continents (1). Every year, IFCCA sets a unifying theme that national associations build on with their own local campaigns.

The 2026 theme builds on last year's "IBD Has No Borders" campaign and sharpens the focus on a specific problem: access to diagnosis, specialist care, and modern treatments (2). The official IFCCA messaging puts it bluntly: quality IBD care should not depend on geography.

This year, IFCCA's flagship event is being hosted in Singapore on May 16, ahead of the May 19 awareness day. It brings together patient leaders and clinicians from across the Asia-Pacific region, where IBD diagnoses are rising quickly but access to specialist gastroenterology, biologics, and IBD-trained nurses remains very uneven (2). The Global IBD Patient Charter is also being developed under this umbrella, drawing directly on lived-experience data from patients around the world.

If you have ever waited years for a diagnosis, fought a prior authorisation for a biologic, or driven hours to find an IBD-trained gastroenterologist, this is your year to recognise that your experience is part of a global pattern - and that the global community is naming it out loud.

Why "Access to Care" Matters: The Global Picture

The case for an "access" theme is strongest when you put numbers on it.

A Disease Affecting Roughly 10 Million People

IFCCA estimates that around 10 million people worldwide live with inflammatory bowel disease (1). The more recent population-based estimates push that number higher in some regions. A 2025 systematic review and meta-analysis of 215 population-based studies put global IBD prevalence at 229.7 per 100,000 (95% CI 212.4 to 247.0), with Crohn's disease at 84.2 and ulcerative colitis at 120.4 per 100,000 (3).

For a sense of the rising global burden, the 2017 Global Burden of Disease study tracked an increase in age-standardised IBD prevalence from 79.5 per 100,000 in 1990 to 84.3 per 100,000 in 2017 (4). The same study found striking geographic differences: high-income North America had the highest age-standardised prevalence at 422.0 per 100,000, while the Caribbean had the lowest at 6.7 per 100,000 (4).

Why the Gap Is About Access, Not Just Biology

It is tempting to read those numbers as pure biology, but a meaningful share of the gap is about diagnosis access. In many parts of the world, the closest gastroenterologist is hours away, colonoscopies are scarce, advanced cross-sectional imaging is rationed, and biologics are either unavailable or unaffordable. A patient with severe Crohn's in a low-income setting may go years without being formally diagnosed - which then never shows up in prevalence statistics at all.

You can see the same problem inside high-income countries too. Even where the medications exist, access can hinge on insurance, geography, or whether your clinic has an IBD-trained nurse. For patients who have lived through this, our existing piece on Crohn's disease treatment around the world gives more context on how care varies in practice.

"More Than the Gut": The US Foundation's Parallel Campaign

In the United States, the Crohn's & Colitis Foundation is running a parallel World IBD Day 2026 campaign called "IBD Is More Than the Gut" (6). The framing is intentional: May is also Mental Health Awareness Month in the US, and the Foundation is using the overlap to put the often-invisible side of IBD into the conversation.

That includes the parts of life that do not show up on a colonoscopy report:

• Chronic pain and fatigue that linger even in clinical remission.
• Anxiety, depression, and the medical trauma that can come from years of urgent symptoms and hospitalisations.
• The toll on relationships, intimacy, parenting, and work.
• The financial strain of medication co-pays, prior authorisations, and lost work hours.

The Foundation has paired the campaign with a "More Than the Gut Guide", co-created with GI psychologists and the IBD community (6). For patients newly leaning into this side of the disease, our articles on the emotional side of Crohn's, stress and IBD, and the importance of a support group are good companion reads.

The two themes - "IBD Has No Borders" globally and "More Than the Gut" in the US - sit comfortably together. One names the geography of access. The other names what access has to actually cover, beyond a prescription pad.

What's Happening on May 19, 2026

May 19 is not one event. It is hundreds of overlapping ones.

• Landmarks lit purple. Bridges, monuments, and city halls around the world will be illuminated in purple, the recognised color of IBD awareness (1). Past years have included more than 120 landmarks.
• Social media campaigns. Patient organisations across more than 50 countries are coordinating posts under #worldibdday2026 and #ibdhasnoborders (1, 2).
• Virtual community events. Crohn's & Colitis UK is hosting a virtual social event from 6:30 to 8:00 pm UK time and is gathering patient stories from a community of more than 500,000 UK patients, with about 25,000 new diagnoses each year (5).
• Local fundraising and education. National associations are running walks, awareness panels, hospital open days, and clinician education events. Many of these are open to the public; check your national IBD organisation's events page.
• The IFCCA Singapore convening. The international roundtable on May 16, ahead of May 19, brings together patient leaders, clinicians, and policy advocates from the Asia-Pacific region and beyond (2).

You do not have to attend anything to be part of the day. Simply showing up online, in a purple shirt, or by sending a single message counts.

Five Ways to Take Part - Even on a Hard Day

If you are in a flare, exhausted, or just running low on energy for advocacy, here are five low-effort ways to mark May 19. Pick one.

1. Share one fact. Post a single verified statistic - "Around 10 million people worldwide live with IBD" - with the hashtag #worldibdday2026. One post can reach a newly diagnosed patient who has not yet found a community.
2. Wear purple, or post a purple photo. A purple shirt, a purple ribbon, a purple-tinted photo of the sky - any of it makes an invisible illness visible.
3. Tell one new person what IBD really involves. Not the textbook definition - the lived one. The fatigue, the bathroom planning, the medication trade-offs, the way it shapes your week. One honest conversation can shift a friend's or coworker's understanding for years.
4. Donate or volunteer with a patient organisation. IFCCA, the Crohn's & Colitis Foundation (US), Crohn's & Colitis UK, and dozens of national associations all run programs that depend on community support. Our overview of ways to support the fight against Crohn's disease lists practical options.
5. Speak to a decision-maker about one specific access barrier. Not "fix healthcare" - one specific thing. A delayed diagnosis. A denied biologic. A prior authorisation that nearly cost you a flare. Write your representative, your insurer, or your hospital's patient advocate.

Why Your Voice Still Matters

It is easy to feel like one post or one purple ribbon does not change anything. But patient stories continue to drive policy change, clinical guideline updates, and research funding. The Global IBD Patient Charter being developed under IFCCA is built directly on lived-experience data (2). The reason national associations can negotiate for better access at all is that there is a documented community behind them.

If you have lived with IBD long enough, you have something to say - even if "what you have to say" is just that you exist, that you got through this week, and that you would like the next generation of patients to find a faster diagnosis and an easier path to treatment than you did.

That is what World IBD Day 2026 is for.

This article is for informational and awareness purposes only. It is not medical advice. Always consult your gastroenterologist or healthcare provider about your personal IBD care.

Sources

1. World IBD Day - Official site (worldibdday.org). https://worldibdday.org/
2. World IBD Day 2026 - IFCCA. https://www.ifcca-ibd.org/events/world-ibd-day-2026
3. Heydari K, Rahnavard M, Ghahramani S, Hoseini A, et al. Global prevalence and incidence of inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Gastroenterology and Hepatology From Bed to Bench, 2025;18(2). https://pmc.ncbi.nlm.nih.gov/articles/PMC12421925/
4. GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology, 2020. https://pubmed.ncbi.nlm.nih.gov/31648971/
5. Crohn's & Colitis UK - World IBD Day 2026. https://www.crohnsandcolitis.org.uk/get-involved/world-ibd-day
6. Crohn's & Colitis Foundation (US) - World IBD Day 2026. https://www.crohnscolitisfoundation.org/WorldIBDDay